Pituitary diseases and bone

Gherardo Mazziotti, S Frara, A Giustina

Research output: Contribution to journalArticle

Abstract

Neuroendocrinology of bone is a new area of research based on the evidence that pituitary hormones may directly modulate bone remodeling and metabolism. Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia. As in other forms of secondary osteoporosis, pituitary diseases generally affect bone quality more than bone quantity, and fractures may occur even in the presence of normal or low-normal bone mineral density as measured by dual-energy X-ray absorptiometry, making difficult the prediction of fractures in these clinical settings. Treatment of pituitary hormone excess and deficiency generally improves skeletal health, although some patients remain at high risk of fractures, and treatment with bone-active drugs may become mandatory. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary diseases. (Endocrine Reviews 39: 440 – 488, 2018) Copyright © 2018 Endocrine Society
Original languageEnglish
Pages (from-to)440-488
Number of pages49
JournalEndocrine Reviews
Volume39
Issue number4
DOIs
Publication statusPublished - 2018

Fingerprint

Pituitary Diseases
Bone and Bones
Pituitary Hormones
Neuroendocrinology
Pituitary ACTH Hypersecretion
Hypopituitarism
Hyperprolactinemia
Acromegaly
Bone Remodeling
Bone Fractures
Photon Absorptiometry
Bone Density
Osteoporosis
Health
Therapeutics
Research
Pharmaceutical Preparations

Cite this

Pituitary diseases and bone. / Mazziotti, Gherardo; Frara, S; Giustina, A.

In: Endocrine Reviews, Vol. 39, No. 4, 2018, p. 440-488.

Research output: Contribution to journalArticle

Mazziotti, Gherardo ; Frara, S ; Giustina, A. / Pituitary diseases and bone. In: Endocrine Reviews. 2018 ; Vol. 39, No. 4. pp. 440-488.
@article{0640053570464acd8efd1e42ce7027e7,
title = "Pituitary diseases and bone",
abstract = "Neuroendocrinology of bone is a new area of research based on the evidence that pituitary hormones may directly modulate bone remodeling and metabolism. Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia. As in other forms of secondary osteoporosis, pituitary diseases generally affect bone quality more than bone quantity, and fractures may occur even in the presence of normal or low-normal bone mineral density as measured by dual-energy X-ray absorptiometry, making difficult the prediction of fractures in these clinical settings. Treatment of pituitary hormone excess and deficiency generally improves skeletal health, although some patients remain at high risk of fractures, and treatment with bone-active drugs may become mandatory. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary diseases. (Endocrine Reviews 39: 440 – 488, 2018) Copyright {\circledC} 2018 Endocrine Society",
author = "Gherardo Mazziotti and S Frara and A Giustina",
year = "2018",
doi = "10.1210/er.2018-00005",
language = "English",
volume = "39",
pages = "440--488",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Pituitary diseases and bone

AU - Mazziotti, Gherardo

AU - Frara, S

AU - Giustina, A

PY - 2018

Y1 - 2018

N2 - Neuroendocrinology of bone is a new area of research based on the evidence that pituitary hormones may directly modulate bone remodeling and metabolism. Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia. As in other forms of secondary osteoporosis, pituitary diseases generally affect bone quality more than bone quantity, and fractures may occur even in the presence of normal or low-normal bone mineral density as measured by dual-energy X-ray absorptiometry, making difficult the prediction of fractures in these clinical settings. Treatment of pituitary hormone excess and deficiency generally improves skeletal health, although some patients remain at high risk of fractures, and treatment with bone-active drugs may become mandatory. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary diseases. (Endocrine Reviews 39: 440 – 488, 2018) Copyright © 2018 Endocrine Society

AB - Neuroendocrinology of bone is a new area of research based on the evidence that pituitary hormones may directly modulate bone remodeling and metabolism. Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia. As in other forms of secondary osteoporosis, pituitary diseases generally affect bone quality more than bone quantity, and fractures may occur even in the presence of normal or low-normal bone mineral density as measured by dual-energy X-ray absorptiometry, making difficult the prediction of fractures in these clinical settings. Treatment of pituitary hormone excess and deficiency generally improves skeletal health, although some patients remain at high risk of fractures, and treatment with bone-active drugs may become mandatory. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary diseases. (Endocrine Reviews 39: 440 – 488, 2018) Copyright © 2018 Endocrine Society

U2 - 10.1210/er.2018-00005

DO - 10.1210/er.2018-00005

M3 - Article

VL - 39

SP - 440

EP - 488

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 4

ER -